UPDATE 1-FDA staff backs Medicines Co's once-rejected blood clot preventer

April 13 (Reuters) - An intravenous blood clot preventer developed by The Medicines Co should be approved by the U.S. Food and Drug Administration, FDA staff reviewers concluded.